|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Resveratrol blocks intedeukin-1/3- induced activation of the nuclear tran- scription factor NF- KB, inhibits proliferation, causes S- phase arrest,and induces apoptosis of acute myeloid leukemia cells 显示文摘 | ESTROV Z SHISHODIA S FADERL S | 2003 | Blood2003，102，3： | 1 |
| 2 | Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor, PIXY-321, stem cell factor, interleukin-3, and interleukin-7: receptor binding and effects on clonogenic proliferation in acute lymphoblastic leukemia显示文摘 | Drach D Estrov Z Zhao S | 1994 | Leuklymphoma1994，16，12： | 1 |
| 3 | Phase 11 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including post myeloproliferative neoplasms ( MPN ) acute myeloid leukemia ( AML ) 显示文摘 | EGHTEDAR A VERSTOVSEK S ESTROV Z | 2012 | Blood2012，119，20： | 1 |
| 4 | Synergistic induction of apoptosis by simultaneous disruption of the Bcl-2 and MEK/MAPK pathways in acute myelogenous leukemia显示文摘 | Milella M Estrov Z Kornblau SM | 2002 | Blood2002，99，9： | 1 |
| 5 | Expression and function of leptin receptor isoforms in myeloid leukemia and myelodysplastic syndromes:proliferative and anti-apoptotic activities显示文摘 | onopleva M Mikhail A Estrov Z | 1999 | Blood1999，93，5： | 1 |
| 6 | The biology of chronic myeloid leukemia 显示文摘 | Faded S Talpaz M Estrov V | 1999 | New Engl J Mede1999，165，3： | 1 |
| 7 | The biology of chronic myeloid leukemia显示文摘 | FADERL S TALPAZ M ESTROV Z | 1999 | N Engl J Med1999，341，3： | 1 |
| 8 | Eradication of leukemia stem cells as a new goal of therapy in ceukemia 显示文摘 | Ravandi F Estrov Z | 2006 | Clin Cancer Res2006，12，2： | 1 |
| 9 | Adult stem cells for tissue repair-- a new therapeutic concept显示文摘 | Korbling M Estrov Z | 2003 | N Engl J Med2003，349，6： | 1 |
| 10 | High levels ofvascular endothelial growth factor receptor- 2 correlate with shortenedsurvival in chronic lymphocytic leukemia显示文摘 | Ferrajoli A Manshouri T Estrov Z | 2001 | Clin Cancer Res2001，7，4： | 1 |
| 11 | Long- term outcomes of 107 patients with myelofibrosis receiving JAKI/ JAK2 inhibitor ruxolitinib: survival advantage in comparison to matched historical controls显示文摘 | VERSTOVSEK S KANTARJIAN HM ESTROV Z | 2012 | Blood2012，120，6： | 1 |
| 12 | Antinuclear autoantibodies as potential antineoplastic agents显示文摘 | Torchilin VP Iakoubov LZ Estrov Z | 2001 | Trends Immunol2001，22，8： | 1 |
| 13 | Adult stem cells for tissue repair-a new ther-apeutic concept显示文摘 | Korbling M Estrov Z | 2003 | N Engl J Med2003，349，6： | 1 |
| 14 | Phase II study of the JAK2 inhibitor, INCB018424, in patients with refractory leukemias including post-myeloproliferative disorder (MPD) acute myeloid leukemia (sAML) 显示文摘 | EGHTEDAR AVS CORTES JE ESTROV Z | 2011 | ASH Annual Meeting Abstracts2011，116，： | 1 |
| 15 | Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148) 显示文摘 | Beran M Cao X Estrov Z | 1998 | Clin Cancer Res1998，4，： | 1 |
| 16 | Antinuclear autoantibodies as potential antineoplastic agents显示文摘 | Torchilin VP Iakoubov LZ Estrov Z | 2001 | Trends Immunol2001，22，8： | 1 |
| 17 | Liposomal Bcl-2 antisense oligonueleotides enhance proliferation, sensitize acute myeloid leukemia to cytosine-arabinoside, and induce apoptosis independent of other antiapoptotic proteins显示文摘 | Konopleva M Tari AM Estrov Z | 2000 | Blood2000，95，12： | 1 |
| 18 | Eradication of leukemia stem ceils as a new goal of therapy in leukemia显示文摘 | RAVANDI V ESTROV Z | 2006 | Clin Cancer Res2006，12，2： | 1 |
| 19 | High levels of vascular endothelial growth factor receptor-2 correlate with shortened survival in chronic lymphocytic leukemia 显示文摘 | Manshouri T Estrov Z | 2001 | Clin Cancer Res2001，7，4： | 1 |
| 20 | The biology of chronic myeloid leukemia显示文摘 | Faderl S Talpaz M Estrov Z | 1999 | N Engl J Med1999，341，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员